Dong-A ST Launches Anemia Treatment Biosimilar "Dabecron" in UAE
Plans to Expand Sales in Neighboring Countries
Dong-A ST announced on October 12 that it had launched Dabecron, a biosimilar treatment for anemia whose active ingredient is darbepoetin alfa, in the United Arab Emirates (UAE).
Product image of Dabecron (DA-3880), a darbepoetin alfa biosimilar developed by Dong-A ST. Dong-A ST
View original imageThe launch marks the first commercialization of Dabecron (project code DA-3880) in the MENA region (the Middle East and North Africa). Dong-A ST plans to use this as a foothold to expand sales in neighboring countries.
In November 2024, Dong-A ST signed a licensing agreement with UAE pharmaceutical company Julphar for Dabecron in 18 countries across the MENA region. Under the agreement, Julphar is responsible for obtaining marketing approvals and commercializing the product in the region. Julphar obtained marketing approval for Dabecron in the UAE in June 2026 and has since completed its local launch.
Dabecron is a biosimilar of darbepoetin alfa, a second-generation treatment for anemia. It is used to treat anemia in patients with chronic kidney disease and anemia caused by cancer chemotherapy.
In 2014, Dong-A ST signed a technology-export agreement with Japan's Sanwa Kagaku Kenkyusho (SKK) for the development and sale of Dabecron in Japan. After obtaining manufacturing and marketing approval in Japan in 2019, the product has been sold under the name "Darbepoetin Alfa BS Injection Sanwa." Sales in Japan rose approximately 62%, from 16.5 billion won in 2024 to 26.7 billion won in 2025.
Dong-A ST is marketing or developing Dabecron as a Nesp biosimilar in Japan, the MENA region, and Türkiye. At the same time, it is pursuing development as an Aranesp biosimilar for major markets, including the United States and Europe.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A Dong-A ST official said, "The successful marketing approval and launch of Dabecron in the UAE have laid the groundwork for expanding into the MENA market. Through our partnership with Julphar, we will expand the number of countries where the product is sold and continue development without disruption to pursue entry into major global markets, including the United States and Europe."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.